Low Rates of Adoption and Implementation of Rapid HIV Testing in Substance Use Disorder Treatment Programs

Journal of Substance Abuse Treatment
Jemima A FrimpongLisa R Metsch

Abstract

Rapid HIV testing (RHT) greatly increases the proportion of clients who learn their test results. However, existing studies have not examined the adoption and implementation of RHT in programs treating persons with substance use disorders, one of the population groups at higher risk for HIV infection. We examined 196 opioid treatment programs (OTPs) using data from the 2011 National Drug Abuse Treatment System Survey (NDATSS). We used logistic regressions to identify client and organizational characteristics of OTPs associated with availability of on-site RHT. We then used zero-inflated negative binomial regressions to measure the association between the availability of RHT on-site and the number of clients tested for HIV. Only 31.6% of OTPs offered on-site rapid HIV testing to their clients. Rapid HIV testing was more commonly available on-site in larger, publicly owned and better-staffed OTPs. On the other hand, on-site rapid HIV testing was less common in OTPs that prescribed only buprenorphine as a method of opioid dependence treatment. The availability of rapid HIV testing on-site reduced the likelihood that an OTP did not test any of its clients during the prior year. But on-site availability rapid HIV testing was not oth...Continue Reading

References

Sep 23, 1988·JAMA : the Journal of the American Medical Association·A Donabedian
Nov 11, 2005·The Milbank Quarterly·Avedis Donabedian
Sep 26, 2006·Journal of Substance Abuse Treatment·Thomas D'Aunno
Oct 13, 2006·Current HIV/AIDS Reports·Carlos Franco-ParedesCarlos del Rio
Mar 3, 2007·Journal of the International Association of Physicians in AIDS Care : JIAPAC·Oscar GruskyAimee-Noelle Swanson
Apr 3, 2008·American Journal of Public Health·Steven KritzJohn Rotrosen
Nov 19, 2008·Journal of Urban Health : Bulletin of the New York Academy of Medicine·Barbara TempalskiSamuel R Friedman
Feb 23, 2010·Journal of Substance Abuse Treatment·Harold A Pollack, Thomas D'Aunno
Mar 17, 2010·The Journal of Infectious Diseases·Christopher D PilcherMatthew Golden
Feb 4, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kevin P DelaneyPeter R Kerndt
Mar 4, 2011·Evaluation and Program Planning·L F HaynesB R Schackman
Jul 7, 2012·AIDS and Behavior·Lu ShiJunyeop Kim
Sep 14, 2012·Drug and Alcohol Dependence·Bruce R SchackmanRochelle P Walensky
Oct 2, 2012·Journal of Substance Abuse Treatment·Robert P SchwartzLisa R Metsch
Jul 17, 2013·Health Services Research·Thomas D'AunnoPeter D Friedmann
Dec 3, 2014·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Emily WestheimerPhilip J Peters
Dec 3, 2014·Evaluation and Program Planning·Kristina B HoodConnie Baird-Thomas
May 3, 2015·Journal of Substance Abuse Treatment·Lydia Aletraris, Paul M Roman
Aug 8, 2015·Substance Abuse Treatment, Prevention, and Policy·Jemima A FrimpongGary Tsai

❮ Previous
Next ❯

Citations

Jun 15, 2016·Drug and Alcohol Dependence·Lytt I GardnerLisa R Metsch
Aug 18, 2017·Substance Abuse Treatment, Prevention, and Policy·Hannah K KnudsenJennifer R Havens
Apr 4, 2019·The Journal of Infectious Diseases·Tara A SchwetzAnthony S Fauci
Sep 11, 2019·Psychiatric Services : a Journal of the American Psychiatric Association·Sunggeun Ethan ParkPeter D Friedmann
Jun 16, 2021·Psychiatric Services : a Journal of the American Psychiatric Association·Nicholas S RianoChristina Mangurian

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.